ArticleCancer reports (Hoboken, N.J.)2026
Virtual Screening of Traditional Chinese Medicine Natural Product Inhibitors Targeting AQP1 for Bladder Cancer.
Article in Cancer reports (Hoboken, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
backgroundBladder cancer (BCa) is the most common and representative type of adult urinary tract urothelial cancer, characterized by high incidence and mortality rates. It has become a major disease threatening public health, highlighting the urgent need for the development of comprehensive treatment strategies, including traditional Chinese medicine, immunotherapy, and genetic diagnostics. Aquaporin-1 (AQP1), a water channel protein, mediates water transport across the cell membrane. Recent studies have shown that aquaporins are involved in the development and progression of malignant tumors. In particular, AQP1 plays a significant role in the pathogenesis of bladder cancer and may serve as a potential target for novel drug development. Natural products, owing to their structural diversity, represent a valuable reservoir of lead compounds for drug discovery. METHODS AND
resultsIn this study, we employed molecular docking and molecular dynamics simulations to screen a library of 2000 traditional Chinese medicine natural compounds for potential activity against the target protein AQP1. The final analysis identified 17 compounds with high binding affinity for the active site of AQP1, indicating their potential as candidate inhibitors. Among these, compounds 8 (Clematignoside), 10 (Ginsenoside Rb2), and 15 (Tannic acid) demonstrated particularly strong binding affinity and complex stability in molecular dynamics simulations.
conclusionThese findings provide a valuable foundation for the rational design of AQP1-targeted pharmacophores and suggest promising candidates for the future development of clinical drugs for the treatment of bladder cancer. The top-ranked compounds, especially compounds 10 and 15, warrant further experimental investigation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.